PNEOO
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 79407300
- Mark type
- Stylized text
- Filed
- 08 Aug 2024
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Cheryl L. Burbach
Goods and services
- Class 001 — Chemicals: Biological preparations for use in cell cultures, other than for medical or veterinary purposes, for boosting cells in the immune system for improved therapies; biological preparations for use in cell cultures, in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents in the nature of complexes of molecules for scientific research and for clinical and industrial use; proteins for use in scientific research; regulatory proteins in raw material for scientific research; the aforementioned goods solely related to respiratory and pulmonary diseases, including lung cancer
- Class 005 — Pharmaceuticals: Medical, biological, and pharmaceutical preparations for the treatment of pulmonary diseases; veterinary preparations for pets, cattle, livestock for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; medical, biological, and pharmaceutical preparations for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattle, livestock for preventing and treating viral, bacterial, and yeast infections; medical, biological, and pharmaceutical preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes, the foregoing solely related to respiratory and pulmonary diseases, including lung cancer; pharmaceutical compounds being a component in pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the prevention of diseases of the respiratory system; diagnostic preparations for medical purposes, the foregoing solely related to respiratory and pulmonary diseases, including lung cancer; chemical diagnostic reagents for medical use, the foregoing solely related to respiratory and pulmonary diseases, including lung cancer
- Class 040 — Treatment of materials: Provision of information, advice and consultancy services in the fields of cell therapy, gene editing, protein replacement, and antibodies, the aforementioned services solely related to respiratory and pulmonary diseases, including lung cancer
- Class 042 — Scientific and technological services: Medical research services for the treatment of various medical disorders, cancer, pulmonary diseases, respiratory diseases, and infectious diseases; Scientific laboratory services; scientific research for medical purposes in the area of diseases; scientific research in the field of genetics and genetic engineering; genetic research for scientific research purposes; genetic mapping for scientific purposes; DNA screening for scientific research purposes; DNA analysis services for scientific research purposes; providing scientific research information in the field of medical disorders and their treatment; biotechnological research relating to enzymatic synthesis; toxicity testing for scientific research purposes; toxicity analysis for scientific research purposes; software as a service (SaaS) featuring artificial intelligence software for use in database management relating to the medical field; software as a service (SaaS) featuring software for use in data base management relating to the medical field; all of the aforementioned services solely related to respiratory and pulmonary diseases, including lung cancer
Owner
- PNEOO B.V., BE
- PNEOO B.V., BE
Prosecution history
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 05 Mar 2026 — NOTIFICATION PROCESSED BY IB
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Feb 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Nov 2025 — REFUSAL PROCESSED BY IB
- 09 Oct 2025 — NON-FINAL ACTION WRITTEN